UNSPSC 51162500: Combination non-opioid-containing antitussives/expectorants

This classification denotes combination drugs and preparations that do not bind to opioid receptors, which do not derive from opium or morphine, which are non-addictive, and which are not narcotics, that a) suppress cough, hence the term ANTITUSSIVES; and/or b) increase mucous excretion, hence the term EXPECTORANTS. These drugs therefore bear the names NON-OPIOID-CONTAINING ANTITUSSIVES and NON-OPIOID-CONTAINING EXPECTORANTS.

Typical combination non-opioid-containing antitussive/expectorant constituents are antimony, antimony potassium tartrate, dextromethorphan, glycerol, iodinated, guaifenesin, iodine, ipecac, potassium guaiacolsulfonate, potassium iodide, and terpin hydrate.

UNSPSC 51162500 Combination non-opioid-containing antitussives/expectorants is a Class code that in recent state and local procurement activity does not meaningfully reflect the code's nominal scope. The two recent opportunities posted under this code involve naloxone procurement and multi-source generic pharmaceuticals and over-the-counter products — neither of which aligns with combination non-opioid antitussives or expectorants. The mismatch suggests either a cataloging error in the source data or that this code is used inconsistently by issuing bodies. The actual work being solicited under this code number includes acquisition of emergency-response pharmaceuticals (naloxone kits and drug deactivation systems) and broad-based generic pharmaceutical supply contracts distributed through authorized wholesalers to state and local facilities.

Activity under this code spans Florida county health systems and multistate cooperative purchasing vehicles. Seminole County, Florida posted an IFB on June 30, 2026 (due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The Minnesota Department of Administration, on behalf of the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued an RFP posted January 20, 2026 (due March 26, 2026) establishing multiple contracts for generic multi-source pharmaceuticals and OTC products for distribution across participating state and local government facilities, including Oregon, through three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC). The code shows limited recent activity and the opportunities posted do not align clearly with the stated pharmaceutical category, suggesting this code may warrant verification before pursuit.